136 related articles for article (PubMed ID: 311341)
1. Cellular immunity against Semliki Forest virus in mice.
Kraaijeveld CA; Harmsen M; Khader Boutahar-Trouw B
Infect Immun; 1979 Feb; 23(2):213-8. PubMed ID: 311341
[TBL] [Abstract][Full Text] [Related]
2. Delayed-type hypersensitivity against Semliki Forest virus in mice.
Kraaijeveld CA; Harmsen M; Khader Boutahar-Trouw B
Infect Immun; 1979 Feb; 23(2):219-23. PubMed ID: 422238
[TBL] [Abstract][Full Text] [Related]
3. Dimethyl dioctadecyl ammoniumbromide as an adjuvant for delayed type hypersensitivity and cellular immunity against Semliki Forest virus in mice.
Kraaijeveld CA; Snippe H; Harmsen M; Khader Boutahar-Trouw B
Arch Virol; 1980; 65(3-4):211-7. PubMed ID: 7416968
[TBL] [Abstract][Full Text] [Related]
4. Adoptive transfer of cross-protection among alphaviruses in mice requires allogeneic stimulation.
Peck R; Wust CJ; Brown A
Infect Immun; 1979 Jul; 25(1):320-7. PubMed ID: 157981
[TBL] [Abstract][Full Text] [Related]
5. Preliminary evidence for cell-mediated immunity in cross-protection among group A arboviruses.
Peck RD; Brown A; Wust CJ
J Immunol; 1975 Feb; 114(2 Pt 1):581-4. PubMed ID: 1079033
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic macrophages: a rapid nonspecific response to viral infection.
Rodda SJ; White DO
J Immunol; 1976 Dec; 117(6):2067-72. PubMed ID: 1086869
[TBL] [Abstract][Full Text] [Related]
7. The responses of normal an athymic mice to infections by togaviruses: strain differentiation in active and adoptive immunization.
Bradish CJ; Fitzgeorge R; Titmuss D
J Gen Virol; 1980 Feb; 46(2):255-65. PubMed ID: 6966674
[TBL] [Abstract][Full Text] [Related]
8. Cross protection among togaviruses in nude mice and littermates.
Latif Z; Gates D; Wust CJ; Brown A
J Gen Virol; 1979 Oct; 45(1):89-98. PubMed ID: 316446
[TBL] [Abstract][Full Text] [Related]
9. Adoptive transfer of immunity against virulent Semliki Forest virus with immune spleen cells from mice infected with avirulent Semliki Forest virus.
Kraaijeveld CA; Benaissa-Trouw BJ; Harmsen M; Snippe H
Arch Virol; 1986; 91(1-2):83-92. PubMed ID: 3489451
[TBL] [Abstract][Full Text] [Related]
10. In vitro heterologous cytotoxicity by T effector cells from mice immunized with Sindbis virus.
Peck R; Brown A; Wust CJ
J Immunol; 1979 Oct; 123(4):1763-6. PubMed ID: 314471
[TBL] [Abstract][Full Text] [Related]
11. Delayed type hypersensitivity against semliki forest virus in mice: local transfer of delayed type hypersensitivity with thioglycollate-induced peritoneal exudate cells.
Kraaijeveld CA; Benaissa-Trouw B; Harmsen M; Snippe H
Int Arch Allergy Appl Immunol; 1984; 73(4):342-6. PubMed ID: 6698625
[TBL] [Abstract][Full Text] [Related]
12. The early responses of mice to respiratory or intraperitoneal infection by defined virulent and avirulent strains of Semliki forest virus.
Bradish CJ; Allner K
J Gen Virol; 1972 Jun; 15(3):205-18. PubMed ID: 5040350
[No Abstract] [Full Text] [Related]
13. Following Acute Encephalitis, Semliki Forest Virus is Undetectable in the Brain by Infectivity Assays but Functional Virus RNA Capable of Generating Infectious Virus Persists for Life.
Fragkoudis R; Dixon-Ballany CM; Zagrajek AK; Kedzierski L; Fazakerley JK
Viruses; 2018 May; 10(5):. PubMed ID: 29783708
[TBL] [Abstract][Full Text] [Related]
14. A delayed-type hypersensitivity-inducing T-cell epitope of Semliki Forest virus mediates effective T-helper activity for antibody production.
Snijders A; Benaissa-Trouw BJ; Visser-Vernooy HJ; Fernandez I; Snippe H; Kraaijeveld CA
Immunology; 1992 Nov; 77(3):322-9. PubMed ID: 1282493
[TBL] [Abstract][Full Text] [Related]
15. Immunomodification and the expression of virulence in mice by defined strains of Semliki Forest virus: the effects of cyclophosphamide.
Bradish CJ; Allner K; Fitzgeorge R
J Gen Virol; 1975 Aug; 28(2):225-37. PubMed ID: 1176966
[TBL] [Abstract][Full Text] [Related]
16. Enhanced resistance of mice to infection with Langat (TP21) virus following pre-treatment with Sindbis or Semliki forest virus.
Oaten SW; Webb HE; Bowen ET
J Gen Virol; 1976 Dec; 33(3):381-8. PubMed ID: 187719
[TBL] [Abstract][Full Text] [Related]
17. Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine.
Mossman SP; Bex F; Berglund P; Arthos J; O'Neil SP; Riley D; Maul DH; Bruck C; Momin P; Burny A; Fultz PN; Mullins JI; Liljeström P; Hoover EA
J Virol; 1996 Mar; 70(3):1953-60. PubMed ID: 8627721
[TBL] [Abstract][Full Text] [Related]
18. The responses of nude-athymic mice to nominally avirulent togavirus infections.
Bradish CJ; Fitzgeorge R; Titmuss D; Baskerville A
J Gen Virol; 1979 Mar; 42(3):555-66. PubMed ID: 311822
[TBL] [Abstract][Full Text] [Related]
19. A vaccine against Semliki Forest virus consisting of a monoclonal anti-idiotypic antibody cross-linked to a protein which contains virus-specific T-helper cell epitopes.
Kraaijeveld CA; Oosterlaken TA; Snijders A; Benaissa-Trouw BJ; Ekstijn GL; Snippe H
Antiviral Res; 1992 Oct; 19(4):275-84. PubMed ID: 1281391
[TBL] [Abstract][Full Text] [Related]
20. Limited infection of mouse brain cell cultures with Semliki forest virus.
Seamer J
Br J Exp Pathol; 1974 Dec; 55(6):606-14. PubMed ID: 4447795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
